{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T21:41:55Z","timestamp":1770414115906,"version":"3.49.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1097\/coc.0b013e3182a78fec","type":"journal-article","created":{"date-parts":[[2013,10,7]],"date-time":"2013-10-07T15:39:47Z","timestamp":1381160387000},"page":"508-513","source":"Crossref","is-referenced-by-count":17,"title":["Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma"],"prefix":"10.1097","volume":"38","author":[{"given":"Maria R.","family":"Pelizzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Torresan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella M.","family":"Boschin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Nacamulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianmaria","family":"Pennelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susi","family":"Barollo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Rubello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Mian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210128","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2265.2004.02037.x","article-title":". Medullary thyroid carcinoma.","volume":"61","author":"Leboulleux","year":"2004","journal-title":"Clin Endocrinol"},{"key":"R2-12-20210128","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1089\/thy.1998.8.517","article-title":". Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986.","volume":"8","author":"Girelli","year":"1998","journal-title":"Thyroid"},{"key":"R3-12-20210128","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1056\/NEJM199409293311302","article-title":". Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.","volume":"331","author":"Lips","year":"1994","journal-title":"N Engl J Med"},{"key":"R4-12-20210128","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of RET proto-oncogene in multiple endocrine neoplasia type 2A.","volume":"363","author":"Mulligan","year":"1993","journal-title":"Nature"},{"key":"R5-12-20210128","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1530\/eje.0.1410468","article-title":". Early or prophylactic thyroidectomy in MEN 2FMTC gene carriers: results in 71 thyroidectomized patients.","volume":"141","author":"Niccoli-Sire","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"R6-12-20210128","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.jpedsurg.2010.03.019","article-title":". Role of RET codonic mutations in the surgical management of medullary thyroid carcinoma in pediatric age multiple endocrine neoplasm type 2 syndromes.","volume":"45","author":"Spinelli","year":"2010","journal-title":"J Pediatric Surg"},{"key":"R7-12-20210128","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1445-2197.2006.03783.x","article-title":". New era: prophylactic surgery for patients with multiple endocrine neoplasia-2a.","volume":"76","author":"Gosnell","year":"2006","journal-title":"ANZ J Surg"},{"key":"R8-12-20210128","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/thy.2008.0403","article-title":". Medullary thyroid cancer: management guidelines of the American Thyroid Association.","volume":"19","author":"Kloos","year":"2009","journal-title":"Thyroid"},{"key":"R9-12-20210128","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1530\/EJE-11-0079","article-title":". Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification.","volume":"164","author":"Mian","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"R10-12-20210128","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":". The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA"},{"key":"R12-12-20210128","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa012915","article-title":". European Multiple Endocrine Neoplasia (EUROMEN) Study Group. Early malignant progression of hereditary medullary thyroid cancer.","volume":"349","author":"Machens","year":"2003","journal-title":"N Engl J Med"},{"key":"R13-12-20210128","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/ejso.2002.1378","article-title":". Acceptable age for prophylactic surgery in children with multiple endocrine neoplasia type 2a.","volume":"29","author":"Kahraman","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"R14-12-20210128","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1210\/jc.2008-0660","article-title":". Clinical and economic outcomes of thyroid and parathyroid surgery in children.","volume":"93","author":"Sosa","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-12-20210128","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":". Guidelines for diagnosis and therapy of MEN type 1 and type 2.","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R16-12-20210128","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/thy.2009.0144","article-title":"Prophylactic thyroidectomy in RET carriers at risk for hereditary medullary thyroid cancer.","volume":"19","author":"Machens","year":"2009","journal-title":"Thyroid"},{"key":"R17-12-20210128","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10689-009-9250-z","article-title":". Characterization of the largest kindred with MEN2A due to a Cys609Ser RET mutation.","volume":"8","author":"Mian","year":"2009","journal-title":"Fam Cancer"},{"key":"R18-12-20210128","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s002689900463","article-title":". Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience.","volume":"22","author":"Dralle","year":"1998","journal-title":"World J Surg"},{"key":"R20-12-20210128","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2796.2004.01423.x","article-title":". Advances in the management of hereditary medullary thyroid cancer.","volume":"257","author":"Machens","year":"2005","journal-title":"J Intern Med"},{"key":"R21-12-20210128","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJMoa043999","article-title":". Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.","volume":"353","author":"Skinner","year":"2005","journal-title":"N Engl J Med"},{"key":"R22-12-20210128","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1530\/eje.1.02216","article-title":". Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype.","volume":"155","author":"Frank-Raue","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"R23-12-20210128","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/jc.2011-2046","article-title":". The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center.","volume":"97","author":"Elisei","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0b013e3182a78fec","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:10:23Z","timestamp":1620951023000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-201510000-00012"}},"subtitle":["A 26-year Monoinstitutional Experience"],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e3182a78fec","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}